In an embodiment, a melt polymerization process comprises melt polymerizing a carbonate compound and a dihydroxy compound in the presence of a catalyst composition to form a polycarbonate; and adding an end-capping agent comprising a mono-phenolic compound to the polycarbonate, wherein the adding of the end-capping agent comprises at least one of adding the end-capping agent just upstream of a final polymerization unit, adding the end-capping agent directly into the final polymerization unit, and adding the end-capping agent downstream of the final polymerization unit; wherein a molecular weight of the polycarbonate increases by less than 10% downstream of the final polymerization unit.

In an embodiment, a melt polymerization process comprises melt polymerizing a carbonate compound and a dihydroxy compound in the presence of a catalyst composition to form a polycarbonate; and adding an end-capping agent comprising a mono-phenolic compound to the polycarbonate, wherein the adding of the end-capping agent comprises at least one of adding the end-capping agent just upstream of a final polymerization unit, adding the end-capping agent directly into the final polymerization unit, and adding the end-capping agent downstream of the final polymerization unit; wherein a molecular weight of the polycarbonate increases by less than 10% downstream of the final polymerization unit.

Antimicrobial cationic polycarbonates and polyurethanes have been prepared comprising one or more pendent guanidinium and/or isothiouronium groups. Additionally, antimicrobial particles were prepared having a silica core linked to surface groups comprising a guanidinium and/or isothiouronium group. The cationic polymers and cationic particles can be potent antimicrobial agents against Gram-negative microbes, Gram-positive microbes, and/or fungi.

Antimicrobial cationic polycarbonates and polyurethanes have been prepared comprising one or more pendent guanidinium and/or isothiouronium groups. Additionally, antimicrobial particles were prepared having a silica core linked to surface groups comprising a guanidinium and/or isothiouronium group. The cationic polymers and cationic particles can be potent antimicrobial agents against Gram-negative microbes, Gram-positive microbes, and/or fungi.

In an embodiment, a polycarbonate polymerization process comprises interfacially polymerizing a carbonate compound and dihydroxy compound in the presence of an interfacial catalyst to form a polycarbonate and adding a viscosity reducing agent and a transesterification catalyst to polycarbonate upstream of a first filter to form an adjusted polycarbonate. The first filter can be replaced with a replacement filter and the adjusted polycarbonate can be introduced to the replacement filter. The flow can be diverted to a replacement filter. The process further comprises reducing the addition rate of the viscosity reducing agent and the transesterification catalyst until the addition rate is 0 mol/hr.

In an embodiment, a polycarbonate polymerization process comprises interfacially polymerizing a carbonate compound and dihydroxy compound in the presence of an interfacial catalyst to form a polycarbonate and adding a viscosity reducing agent and a transesterification catalyst to polycarbonate upstream of a first filter to form an adjusted polycarbonate. The first filter can be replaced with a replacement filter and the adjusted polycarbonate can be introduced to the replacement filter. The flow can be diverted to a replacement filter. The process further comprises reducing the addition rate of the viscosity reducing agent and the transesterification catalyst until the addition rate is 0 mol/hr.

The present invention relates to a process for producing hydrosilylatable, eugenol-based polyethers, to the conversion thereof into polyether siloxanes and also to the products that may be produced by this process and to the use of said products as surfactants.

Biocompatible methods of functionalising inert surfaces for use in biological applications are described. The methods employ the use of synthetic constructs of the generic structure F-S-L (where F is a functional moiety, S is a spacer selected to provide a construct that is dispersible in water, and L is a diacyl- or dialkyl-glycerophospholipid). An object of the invention is to localise or immobilise functional moieties to the inert surface of a substrate wherein the surface is comprised of glass, silver, polyamide, polycarbonate, polypropylene, polyethersulfone, polytetrafluoroethylene or polyvinylidene fluoride, and the substrate is comprised of a fibre, membrane, microsphere or nanosphere.

Biocompatible methods of functionalising inert surfaces for use in biological applications are described. The methods employ the use of synthetic constructs of the generic structure F-S-L (where F is a functional moiety, S is a spacer selected to provide a construct that is dispersible in water, and L is a diacyl- or dialkyl-glycerophospholipid). An object of the invention is to localise or immobilise functional moieties to the inert surface of a substrate wherein the surface is comprised of glass, silver, polyamide, polycarbonate, polypropylene, polyethersulfone, polytetrafluoroethylene or polyvinylidene fluoride, and the substrate is comprised of a fibre, membrane, microsphere or nanosphere.

The present invention relates to a composition comprising at least one compound of the formula (1)

##STR00001##

wherein
R.sup.1, R.sup.2 and R.sup.3 are the same or different and denote a C.sub.1-C.sub.10-alkyl, and at least one carrier resin.